David K.B. Li

发表

Complementary information from multi-exponential T 2 relaxation and diffusion tensor imaging reveals differences between multiple sclerosis lesions

Anthony Traboulsee, Alex L. MacKay, Shannon H. Kolind, 2008, NeuroImage.

Magnetic resonance imaging results of the PRISMS trial: A randomized, double‐blind, placebo‐controlled study of interferon‐β1a in relapsing‐remitting multiple sclerosis

D. Paty, David K.B. Li, 1999 .

Deep 3D Convolutional Encoder Networks With Shortcuts for Multiscale Feature Integration Applied to Multiple Sclerosis Lesion Segmentation

Lisa Tang, Youngjin Yoo, Roger C. Tam, 2016, IEEE Transactions on Medical Imaging.

Texture analysis differentiates persistent and transient T1 black holes at acute onset in multiple sclerosis: A preliminary study

Anthony Traboulsee, Yinshan Zhao, Yinshan Zhao, 2011, Multiple sclerosis.

Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS

Ravi S. Menon, C. Crainiceanu, D. Arnold, 2019, Neurology.

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

F. Barkhof, L. Kappos, P. Calabresi, 2011, The Lancet.

Quantitative neuroimaging measures of myelin in the healthy brain and in multiple sclerosis

I. Vavasour, A. Traboulsee, Alexander Rauscher, 2019, Human brain mapping.

MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials

David H. Miller, F. Barkhof, M. Rovaris, 2012, Nature Reviews Neurology.

MR evidence of long T2 water in pathological white matter

B. Mädler, A. MacKay, C. Laule, 2007, Journal of magnetic resonance imaging : JMRI.

Global loss of myelin water over 5 years in multiple sclerosis normal-appearing white matter

B. Mädler, A. MacKay, C. Laule, 2017, Multiple sclerosis.

Education, and the balance between dynamic and stationary functional connectivity jointly support executive functions in relapsing–remitting multiple sclerosis

Anthony Traboulsee, Irene Vavasour, Martin J McKeown, 2018, Human brain mapping.

Associations Between Findings From Myelin Water Imaging and Cognitive Performance Among Individuals With Multiple Sclerosis

Adam V. Dvorak, C. Laule, I. Vavasour, 2020, JAMA Network Open.

Susceptibility‐sensitive MRI of multiple sclerosis lesions and the impact of normal‐appearing white matter changes

Anthony Traboulsee, Gregor Kasprian, Christian Kames, 2017, NMR in biomedicine.

Data fusion detects consistent relations between non-lesional white matter myelin, executive function, and clinical characteristics in multiple sclerosis

Martin J. McKeown, Anthony Traboulsee, Irene Vavasour, 2019, NeuroImage: Clinical.

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis

Anthony Traboulsee, Dawn Langdon, D. Goodin, 2011, Journal of Neurology, Neurosurgery & Psychiatry.

Cervical cord myelin water imaging shows degenerative changes over one year in multiple sclerosis but not neuromyelitis optica spectrum disorder

Gareth J. Barker, Shannon Kolind, Anthony L. Traboulsee, 2017, NeuroImage: Clinical.

Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis☆

A. Traboulsee, David K.B. Li, R. Tam, 2012, NeuroImage: Clinical.

Patterns of cognitive impairment in relapsing–remitting multiple sclerosis and their relationship to neuropathology on magnetic resonance images.

D. Paty, David K.B. Li, L. Ryan, 1996 .

A 24-month advanced magnetic resonance imaging study of multiple sclerosis patients treated with alemtuzumab

A. MacKay, C. Laule, I. Vavasour, 2019, Multiple sclerosis.

Short-term stability of T1 and T2 relaxation measures in multiple sclerosis normal appearing white matter

Alex L. MacKay, Irene M. Vavasour, Burkhard Mädler, 2012, Journal of Neurology.

Rapid myelin water imaging in human cervical spinal cord.

Anthony Traboulsee, Roger Tam, Irene Vavasour, 2016, Magnetic resonance in medicine.

Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b

Dawn Langdon, Anthony L Traboulsee, Marcelo Kremenchutzky, 2019, Multiple sclerosis.

Establishing Long-Term Efficacy in Chronic Disease: Use of Recursive Partitioning and Propensity Score Adjustment to Estimate Outcome in MS

D. Goodin, A. Traboulsee, David K.B. Li, 2011, PloS one.

Three-dimensional MRI sequences in MS diagnosis and research

A. Traboulsee, Alexander Rauscher, David K.B. Li, 2019, Multiple sclerosis.

Myelin Damage in Normal Appearing White Matter Contributes to Impaired Cognitive Processing Speed in Multiple Sclerosis

Adam V. Dvorak, C. Laule, I. Vavasour, 2019, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Cortical morphology predicts placebo response in multiple sclerosis

Mariya V. Cherkasova, V. Sossi, M. Cherkasova, 2019, Scientific Reports.

Needle orientation for transhepatic cholangiography: CT localization of the porta hepatis

David K.B. Li, H. Burhenne, 1980, Gastrointestinal Radiology.

Magnetic Resonance Imaging (MRI) As an Outcome Measure in Multiple Sclerosis

D. Paty, J. Oger, David K.B. Li, 1993 .

An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis: Advocacy, Dissemination, and Implementation Strategies.

D. Reich, F. Barkhof, F. Paul, 2020, International journal of MS care.

Corpus Callosum Segmentation in MS Studies Using Normal Atlases and Optimal Hybridization of Extrinsic and Intrinsic Image Cues

Lisa Tang, Ghassan Hamarneh, Roger C. Tam, 2015, MICCAI.

Detection of Unusual Increases in MRI Lesion Counts in Individual Multiple Sclerosis Patients

Yinshan Zhao, A. Traboulsee, David K.B. Li, 2014 .

Correlating new directional measures of myelin and axonal integrity in T2-weighted MRI with quantitative histology in multiple sclerosis

C. Laule, G. Moore, David K.B. Li, 2019, Journal of Neuroscience Methods.

Advanced imaging in lesion and normal-appearing white matter over 2 years in MS patients treated with alemtuzumab (S29.009)

A. MacKay, C. Laule, I. Vavasour, 2015 .

Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels

A. Traboulsee, David K.B. Li, J. Kuhle, 2022, Multiple sclerosis.

Effects of mid sagittal plane selection on corpus callosal area

G. Hamarneh, A. Traboulsee, David K.B. Li, 2006 .

Myelin water imaging data analysis in less than one minute

Roger C. Tam, Anthony Traboulsee, Hanwen Liu, 2020, NeuroImage.

Deep grey matter injury in multiple sclerosis: A NAIMS consensus statement.

D. Greve, D. Arnold, D. Reich, 2021, Brain : a journal of neurology.

2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

O. Ciccarelli, D. Reich, F. Barkhof, 2021, The Lancet Neurology.

Safety and efficacy of venoplasty in MS

J. Illes, A. Traboulsee, A. Sadovnick, 2018, Neurology.

Orientation Dependent MR Signal Decay Differentiates between People with MS, Their Asymptomatic Siblings and Unrelated Healthy Controls

Anthony Traboulsee, Vanessa Wiggermann, Lindsay Machan, 2015, PloS one.

Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study

Yinshan Zhao, A. Traboulsee, Alexander Rauscher, 2014, The Lancet.

Comparison of MERGE and axial T2-weighted fast spin-echo sequences for detection of multiple sclerosis lesions in the cervical spinal cord.

Yinshan Zhao, A. Traboulsee, David K.B. Li, 2012, AJR. American journal of roentgenology.

Myelin water imaging of multiple sclerosis at 7 T: Correlations with histopathology

Piotr Kozlowski, Alex L. MacKay, David K. B. Li, 2008, NeuroImage.

Reproducibility and reliability of MR measurements in white matter: Clinical implications

Alex L. MacKay, Irene M. Vavasour, David K. B. Li, 2006, NeuroImage.

Machine learning in secondary progressive multiple sclerosis: an improved predictive model for short-term disability progression

Roger Tam, Anthony L Traboulsee, A. Traboulsee, 2019, Multiple sclerosis journal - experimental, translational and clinical.

Metabolic subtypes in patients with schizophrenia

David K.B. Li, L. Kopala, T. Hurwitz, 1993, Biological Psychiatry.

Benefits of high-dose, high-frequency interferon beta-1a in relapsing–remitting multiple sclerosis are sustained to 16 months: Final comparative results of the EVIDENCE trial

D. Goodin, David K.B. Li, H. Panitch, 2005, Journal of the Neurological Sciences.

Impact of exposure to interferon beta-1a on outcomes in patients with relapsing–remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study

L. Kappos, B. Uitdehaag, A. Traboulsee, 2011, Therapeutic advances in neurological disorders.

Cognitive Impairment No Dementia – Neuropsychological and Neuroimaging Characterization of an Amnestic Subgroup

B. L. Beattie, P. Scheltens, H. Feldman, 2008, Dementia and Geriatric Cognitive Disorders.

An ounce of prevention is worth a pound of cure: a cost-effectiveness analysis of incidentally detected aneurysms in functional MRI research.

J. Illes, David K.B. Li, C. Marra, 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study.

X. Montalban, L. Kappos, H. Hartung, 2016, JAMA neurology.

Magnetic resonance frequency shifts during acute MS lesion formation

Anthony Traboulsee, Vanessa Wiggermann, Cornelia Laule, 2013, Neurology.

The role of MRI in the diagnosis of multiple sclerosis.

A. Traboulsee, David K.B. Li, 2006, Advances in neurology.

Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosis

Anthony Traboulsee, Yinshan Zhao, Yinshan Zhao, 2008, Neurology.

Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian Consensus recommendations

D. Arnold, A. Traboulsee, David K.B. Li, 2015, Multiple sclerosis journal - experimental, translational and clinical.

Canadian Expert Panel Recommendations for MRI Use in MS Diagnosis and Monitoring

A. Traboulsee, M. Freedman, David K.B. Li, 2015, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years

A. Bar-Or, A. Traboulsee, M. Freedman, 2012, Multiple sclerosis.

Conventional MR imaging.

Anthony Traboulsee, A. Traboulsee, David K.B. Li, 2008, Neuroimaging clinics of North America.

Conventional MRI Techniques in Multiple Sclerosis

Anthony Traboulsee, Guojun Zhao, Donald W. Paty, 2005 .

Nonlesional diffusely abnormal appearing white matter in clinically isolated syndrome: Prevalence, association with clinical and MRI features, and risk for conversion to multiple sclerosis

C. Laule, I. Vavasour, G. Moore, 2021, Journal of Neuroimaging.

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

Bernhard Hemmer, Ludwig Kappos, Xavier Montalban, 2013, The Lancet Neurology.

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis

A. Traboulsee, M. Freedman, David K.B. Li, 2017, The New England journal of medicine.

Multimodal peripheral fluid biomarker analysis in clinically isolated syndrome and early multiple sclerosis.

H. Vogel, A. Traboulsee, David K.B. Li, 2021, Multiple sclerosis and related disorders.

Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis

F. Barkhof, L. Kappos, A. Bar-Or, 2019, Neurology.

Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing–remitting multiple sclerosis at year 1

A. Traboulsee, Aaron E Miller, David K.B. Li, 2018, BMC Neurology.

Onset of clinical andMRI e ffi cacy of ocrelizumab in relapsing multiple sclerosis

F. Barkhof, L. Kappos, A. Bar-Or, 2022 .

Cervical Spinal Cord Atrophy can be Accurately Quantified Using Head Images

C. Laule, I. Vavasour, A. Traboulsee, 2022, Multiple sclerosis journal - experimental, translational and clinical.

Cervical cord myelin abnormality is associated with clinical disability in multiple sclerosis

C. Laule, I. Vavasour, A. Traboulsee, 2021, Multiple sclerosis.

High-resolution myelin water imaging in post-mortem multiple sclerosis spinal cord: A case report

Stephen Yip, Piotr Kozlowski, Cornelia Laule, 2016, Multiple sclerosis.

Long-Term Efficacy and Safety of Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Week 96 Results of a Phase II, Randomized, Multicenter Trial (S30.006)

F. Barkhof, L. Kappos, P. Calabresi, 2012 .

Randomized, comparative study of interferon &bgr;-1a treatment regimens in MS: The EVIDENCE Trial

D. Goodin, B. Weinshenker, David K.B. Li, 2002 .

Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis.

C. Laule, I. Vavasour, A. Traboulsee, 2021, Multiple sclerosis and related disorders.

Deep Convolutional Encoder Networks for Multiple Sclerosis Lesion Segmentation

Lisa Tang, Youngjin Yoo, Roger C. Tam, 2015, MICCAI.

Clinical and Magnetic Resonance Imaging Changes Correlate in a Clinical Trial Monitoring Cyclosporine Therapy for Multiple Sclerosis

Andrew Riddehough, William Mietlowski, D. Paty, 1997, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Further investigation of safety monitoring guidelines based on magnetic resonance imaging lesion activity in multiple sclerosis clinical trials

Yinshan Zhao, A. Traboulsee, David K.B. Li, 2015, Multiple sclerosis.

Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.

David K.B. Li, R. Spain, D. Bourdette, 2016, Multiple sclerosis and related disorders.

Rapid myelin water imaging in human cervical spinal cord

Anthony Traboulsee, Roger Tam, Irene Vavasour, 2016, Magnetic resonance in medicine.

Accounting for uncertainty in training data to improve machine learning performance in predicting new disease activity in early multiple sclerosis

A. Traboulsee, S. Kolind, David K.B. Li, 2023, Frontiers in Neurology.

Deep learning of brain lesion patterns and user-defined clinical and MRI features for predicting conversion to multiple sclerosis from clinically isolated syndrome

Youngjin Yoo, Anthony Traboulsee, Shannon H. Kolind, 2019, Comput. methods Biomech. Biomed. Eng. Imaging Vis..

Optimizing the Use of Radiologist Seed Points for Improved Multiple Sclerosis Lesion Segmentation

Roger C. Tam, Erick Wong, David K. B. Li, 2010, IEEE Transactions on Biomedical Engineering.

MS, MRI, and the 2010 McDonald criteria

M. Freedman, David K.B. Li, F. Grand'Maison, 2012, Neurology.

Corticospinal tract integrity measured using transcranial magnetic stimulation and magnetic resonance imaging in neuromyelitis optica and multiple sclerosis

Anthony Traboulsee, Shannon H. Kolind, Irene M. Vavasour, 2016, Multiple sclerosis.

Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study.

D. Goodin, David K.B. Li, H. Panitch, 2005, Archives of neurology.

Prevalence of Extracranial venous Narrowing on Magnetic Resonance Venography is Similar in People with Multiple Sclerosis, Their Siblings, and Unrelated Healthy Controls: A Blinded, Case-Control Study

Yinshan Zhao, A. Traboulsee, Alexander Rauscher, 2017, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

Anisotropic cerebral vascular architecture causes orientation dependency in cerebral blood flow and volume measured with dynamic susceptibility contrast magnetic resonance imaging

Nils Daniel Forkert, Anthony Traboulsee, Vanessa Wiggermann, 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Diffusely Abnormal White Matter, T2 Burden of Disease, and Brain Volume in Relapsing‐Remitting Multiple Sclerosis

C. Laule, I. Vavasour, Yinshan Zhao, 2018, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Increased mean R2* in the deep gray matter of multiple sclerosis patients: Have we been measuring atrophy?

A. Traboulsee, Alexander Rauscher, A. Sadovnick, 2018, Journal of magnetic resonance imaging : JMRI.

15 – MRI in Multiple Sclerosis

D. Paty, David K.B. Li, Guojun Zhao, 2000 .

The use of MRI as an outcome measure in clinical trials.

Anthony Traboulsee, Guojun Zhao, Andrew Riddehough, 2006, Advances in neurology.

Prognostic factors for long-term outcomes in relapsing–remitting multiple sclerosis

L. Kappos, B. Uitdehaag, A. Traboulsee, 2016, Multiple sclerosis journal - experimental, translational and clinical.

Modeling the Variability in Brain Morphology and Lesion Distribution in Multiple Sclerosis by Deep Learning

Youngjin Yoo, Roger C. Tam, Tom Brosch, 2014, MICCAI.

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.

D. Goodin, A. Traboulsee, David K.B. Li, 2009, Clinical therapeutics.

Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

A. Traboulsee, Aaron E Miller, David K.B. Li, 2018, BMC Neurology.

The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis

D. Bates, L. Kappos, H. Hartung, 1997 .

MRI Contributes to the Differentiation Between MS and HTLV-I Associated Myelopathy in British Columbian Coastal Natives

J. Oger, David K.B. Li, A. Howard, 2003, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging

Sheng-Kwei Song, C. Laule, I. Vavasour, 2021, Multiple sclerosis.

Cognitive Performance in Subjects With Multiple Sclerosis Is Robustly Influenced by Gender in Canonical-Correlation Analysis.

Anthony Traboulsee, Irene Vavasour, Sue-Jin Lin, 2017, The Journal of neuropsychiatry and clinical neurosciences.

Effect of different doses of gadolinium contrast agent on clinical outcomes in MS

A. Traboulsee, M. Freedman, S. Kolind, 2019, Multiple sclerosis journal - experimental, translational and clinical.

MRI in the diagnosis of MS

A. A. Eisen, D. Paty, J. Oger, 1988, Neurology.

Role of MRI in the differentiation of ADEM from MS in children

D. Li, B. Banwell, David K.B. Li, 2009, Neurology.

MR imaging of periventricular leukomalacia in childhood.

O Flodmark, D. Li, M. Whitfield, 1989, AJR. American journal of roentgenology.

A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses

R. Scheyer, A. Bar-Or, D. Paty, 2006, Neurology.

Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.

J A Frank, J H Simon, J S Wolinsky, 2006, AJNR. American journal of neuroradiology.

Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS

L. Kappos, B. Uitdehaag, A. Traboulsee, 2006, Neurology.

Importance of magnetic resonance imaging and gadolinium enhancement

D. Paty, David K.B. Li, 1996, Annals of neurology.

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial

D. Goodin, A. Traboulsee, D. Li, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Cross-sectional study assessing long-term safety of interferon-β-1b for relapsing-remitting MS

D. Goodin, A. Traboulsee, D. Li, 2010, Neurology.

Randomized, comparative study of interferon β-1a treatment regimens in MS

D. Goodin, B. Weinshenker, David K.B. Li, 2002, Neurology.

Corpus Callosum Segmentation in Brain MRIs via Robust Target-Localization and Joint Supervised Feature Extraction and Prediction

Lisa Tang, Xingtong Liu, Youngjin Yoo, 2016, MICCAI.

EDSS and MRI burden of disease predict cognitive status at 16 years: data from the long term follow-up study

D. Goodin, A. Traboulsee, David K.B. Li, 2007 .

Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a

A. Traboulsee, Alexander Rauscher, S. Kolind, 2019, Multiple sclerosis journal - experimental, translational and clinical.

Deep Learning of Brain Lesion Patterns for Predicting Future Disease Activity in Patients with Early Symptoms of Multiple Sclerosis

Lisa Tang, Youngjin Yoo, Roger C. Tam, 2016, LABELS/DLMIA@MICCAI.

Week 144 Results of a Phase II, Randomized, Multicenter Trial Assessing the Safety and Efficacy of Ocrelizumab in Patients with Relapsing–Remitting Multiple Sclerosis (RRMS) (S31.004)

F. Barkhof, L. Kappos, P. Calabresi, 2013 .

Cross-sectional study assessing long-term safety of interferon-β-1b for relapsing-remitting MS

D. Goodin, A. Traboulsee, David K.B. Li, 2010, Neurology.

MRI in the diagnosis of pediatric multiple sclerosis

D. Li, B. Banwell, David K.B. Li, 2009, Neurology.

Longitudinal advanced MRI case report of white matter radiation necrosis

C. Laule, I. Vavasour, A. Traboulsee, 2018, Annals of clinical and translational neurology.